Maryland clinic launches outpatient CAR T-cell therapy, expanding community cancer treatment access

The Center for Cancer and Blood Disorders (CCBD) in Maryland has started offering FDA-approved CAR T-cell therapy in an outpatient community setting, led by Dr. Ralph Boccia. This program expands access to advanced immunotherapy for blood cancers like lymphoma and leukemia, bringing cutting-edge treatment closer to patients' homes. CCBD collaborates with local hospitals to ensure patient safety and continues clinical trials to broaden therapy availability. This initiative marks a significant step in making innovative cancer care more accessible outside traditional hospital environments.